Anticoagulants Equal in Aortic Valve Replacement

ACC Conference Reporter

TCT 2015 | SAN FRANCISCO — Bivalirudin (Angiomax) isn't any better than unfractionated heparin (UFH) in transcatheter aortic valve replacement (TAVR), the BRAVO 3 trial showed. Read More >>>

Keywords: Transcatheter Cardiovascular Therapeutics


< Back to Listings